1. Home
  2. CDXC vs CCSI Comparison

CDXC vs CCSI Comparison

Compare CDXC & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXC
  • CCSI
  • Stock Information
  • Founded
  • CDXC 1999
  • CCSI 2021
  • Country
  • CDXC United States
  • CCSI United States
  • Employees
  • CDXC N/A
  • CCSI N/A
  • Industry
  • CDXC Medicinal Chemicals and Botanical Products
  • CCSI Retail: Computer Software & Peripheral Equipment
  • Sector
  • CDXC Health Care
  • CCSI Technology
  • Exchange
  • CDXC Nasdaq
  • CCSI Nasdaq
  • Market Cap
  • CDXC 546.9M
  • CCSI 483.6M
  • IPO Year
  • CDXC N/A
  • CCSI N/A
  • Fundamental
  • Price
  • CDXC $7.63
  • CCSI $23.75
  • Analyst Decision
  • CDXC Strong Buy
  • CCSI Hold
  • Analyst Count
  • CDXC 2
  • CCSI 5
  • Target Price
  • CDXC $8.00
  • CCSI $26.00
  • AVG Volume (30 Days)
  • CDXC 3.0M
  • CCSI 146.8K
  • Earning Date
  • CDXC 10-31-2024
  • CCSI 11-07-2024
  • Dividend Yield
  • CDXC N/A
  • CCSI N/A
  • EPS Growth
  • CDXC N/A
  • CCSI 16.33
  • EPS
  • CDXC 0.02
  • CCSI 4.56
  • Revenue
  • CDXC $91,668,000.00
  • CCSI $351,153,000.00
  • Revenue This Year
  • CDXC $18.64
  • CCSI N/A
  • Revenue Next Year
  • CDXC $20.72
  • CCSI N/A
  • P/E Ratio
  • CDXC $388.80
  • CCSI $5.26
  • Revenue Growth
  • CDXC 9.95
  • CCSI N/A
  • 52 Week Low
  • CDXC $1.32
  • CCSI $11.62
  • 52 Week High
  • CDXC $7.85
  • CCSI $28.10
  • Technical
  • Relative Strength Index (RSI)
  • CDXC 75.32
  • CCSI 50.94
  • Support Level
  • CDXC $6.80
  • CCSI $23.05
  • Resistance Level
  • CDXC $7.67
  • CCSI $25.91
  • Average True Range (ATR)
  • CDXC 0.58
  • CCSI 1.20
  • MACD
  • CDXC 0.07
  • CCSI -0.16
  • Stochastic Oscillator
  • CDXC 91.16
  • CCSI 21.02

About CDXC ChromaDex Corporation

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.

Share on Social Networks: